@article{e6dd8821fbf34221b4bf8dc41aa7af4f,
title = "Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease: A Prespecified Analysis From the FOURIER Trial",
keywords = "ACUTE CORONARY SYNDROMES, MYOCARDIAL-INFARCTION, STATIN THERAPY, ATORVASTATIN, METAANALYSIS, PARTICIPANTS, SIMVASTATIN, CHOLESTEROL, REDUCTION, EFFICACY, 3121 General medicine, internal medicine and other clinical medicine",
author = "Murphy, {Sabina A.} and Pedersen, {Terje R.} and Gaciong, {Zbigniew A.} and Richard Ceska and Maiat Ezhov and Connolly, {Derek L.} and Jukema, {J. Wouter} and Kalman Toth and Tikkanen, {Matti J.} and Kyungah Im and Wiviott, {Stephen D.} and Kurtz, {Christopher E.} and Narimon Honarpour and Giugliano, {Robert R.} and Keech, {Anthony C.} and Sever, {Peter S.} and Sabatine, {Marc S.}",
year = "2019",
month = jul,
doi = "10.1001/jamacardio.2019.0886",
language = "English",
volume = "4",
pages = "613--619",
journal = "JAMA cardiology",
issn = "2380-6583",
publisher = "American Medical Association",
number = "7",
}